Tags

Type your tag names separated by a space and hit enter

Of chloroquine and COVID-19.
Antiviral Res. 2020 05; 177:104762.AR

Abstract

Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.

Links

Publisher Full Text
ncbi.nlm.nih.gov
linkinghub.elsevier.com
PMC Free PDF
Aggregator Full Text

Authors+Show Affiliations

Touret F
Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France. Electronic address: franck.touret@univ-amu.fr.
de Lamballerie X
Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France. Electronic address: xavier.de-lamballerie@univ-amu.fr.

MeSH

Antiviral AgentsBetacoronavirusCOVID-19ChinaChloroquineClinical Trials as TopicCoronavirus InfectionsHumansHydroxychloroquinePandemicsPneumonia, ViralSARS-CoV-2

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32147496

Clinical Trial Links

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

Citation

Touret, Franck, and Xavier de Lamballerie. "Of Chloroquine and COVID-19." Antiviral Research, vol. 177, 2020, p. 104762.
Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral Res. 2020;177:104762.
Touret, F., & de Lamballerie, X. (2020). Of chloroquine and COVID-19. Antiviral Research, 177, 104762. https://doi.org/10.1016/j.antiviral.2020.104762
Touret F, de Lamballerie X. Of Chloroquine and COVID-19. Antiviral Res. 2020;177:104762. PubMed PMID: 32147496.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Of chloroquine and COVID-19. AU - Touret,Franck, AU - de Lamballerie,Xavier, Y1 - 2020/03/05/ PY - 2020/02/29/received PY - 2020/03/02/revised PY - 2020/03/02/accepted PY - 2020/3/10/pubmed PY - 2020/4/24/medline PY - 2020/3/10/entrez KW - 2019-nCoV KW - Antiviral KW - COVID-19 KW - Chloroquine KW - SARS-CoV-2 SP - 104762 EP - 104762 JF - Antiviral research JO - Antiviral Res VL - 177 N2 - Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research. SN - 1872-9096 UR - https://www.unboundmedicine.com/medline/citation/32147496/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S0166-3542(20)30114-5 DB - PRIME DP - Unbound Medicine ER -